Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.84 USD | -4.26% |
|
+0.27% | +35.53% |
06-24 | ITeos Therapeutics, Inc.(NasdaqGM:ITOS) added to S&P Biotechnology Select Industry Index | CI |
06-17 | GSK: Phase III study with iTeos begins | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.53% | 553M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- ITOS Stock
- News iTeos Therapeutics, Inc.
- iTeos Therapeutics : Wedbush Adjusts Price Target on ITeos Therapeutics to $46 From $45, Keeps Outperform Rating